Cargando...
Vaccines, adjuvants and dendritic cell activators – Current Status and Future Challenges
Cancer vaccines offer a low-toxicity approach to induce anticancer immune responses. They have shown promise for clinical benefit with one cancer vaccine approved in the U.S. for advanced prostate cancer. As other immune therapies are now clearly effective for treatment of advanced cancers of many h...
Guardado en:
| Publicado en: | Semin Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621212/ https://ncbi.nlm.nih.gov/pubmed/26320060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2015.05.006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|